![Wan-Jen Hong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wan-Jen Hong
Directeur Technique/Scientifique/R&D chez
IMAGO BIOSCIENCES, INC.
Profil
Wan-Jen Hong currently works at Imago BioSciences, Inc., as Chief Medical Officer from 2021.
Dr. Hong also formerly worked at Genentech, Inc., as Group Medical Director from 2014 to 2021.
Dr. Hong received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from Stanford University School of Medicine.
Postes actifs de Wan-Jen Hong
| Sociétés | Poste | Début |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/05/2021 |
Anciens postes connus de Wan-Jen Hong
| Sociétés | Poste | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Directeur Technique/Scientifique/R&D | 01/10/2024 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Formation de Wan-Jen Hong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
